{"id":"https://openalex.org/W3217463287","doi":"https://doi.org/10.1272/jnms.jnms.2022_89-221","title":"Current Trends in Anti-Cancer Molecular Targeted Therapies: Renal Complications and Their Histological Features","display_name":"Current Trends in Anti-Cancer Molecular Targeted Therapies: Renal Complications and Their Histological Features","publication_year":2021,"publication_date":"2021-11-25","ids":{"openalex":"https://openalex.org/W3217463287","doi":"https://doi.org/10.1272/jnms.jnms.2022_89-221","mag":"3217463287","pmid":"https://pubmed.ncbi.nlm.nih.gov/34840210"},"language":"en","primary_location":{"id":"doi:10.1272/jnms.jnms.2022_89-221","doi":"https://doi.org/10.1272/jnms.jnms.2022_89-221","is_oa":true,"landing_page_url":"https://doi.org/10.1272/jnms.jnms.2022_89-221","pdf_url":"https://www.jstage.jst.go.jp/article/jnms/advpub/0/advpub_JNMS.2022_89-221/_pdf","source":{"id":"https://openalex.org/S118610483","display_name":"Journal of Nippon Medical School","issn_l":"0048-0444","issn":["0048-0444","1345-4676","1347-3409","1884-0108"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["dongbi-b","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320448","host_organization_name":"Medknow","host_organization_lineage":["https://openalex.org/P4310320448","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Medknow","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Nippon Medical School","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.jstage.jst.go.jp/article/jnms/advpub/0/advpub_JNMS.2022_89-221/_pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035937276","display_name":"Akiko Tonooka","orcid":"https://orcid.org/0000-0001-6095-578X","observed_orcids":["https://orcid.org/0000-0001-6095-578X"]},"institutions":[{"id":"https://openalex.org/I3020605285","display_name":"Tokyo Metropolitan Komagome Hospital","ror":"https://ror.org/04eqd2f30","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I3020605285"]},{"id":"https://openalex.org/I42570316","display_name":"Japanese Foundation For Cancer Research","ror":"https://ror.org/00bv64a69","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I42570316"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akiko Tonooka","raw_affiliation_strings":["Department of Pathology, Tokyo Metropolitan Cancer and Infectious Diseases Komagome Hospital","Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Tokyo Metropolitan Cancer and Infectious Diseases Komagome Hospital","institution_ids":["https://openalex.org/I3020605285"]},{"raw_affiliation_string":"Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research","institution_ids":["https://openalex.org/I42570316"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059029488","display_name":"Ryuji Ohashi","orcid":"https://orcid.org/0000-0001-7053-038X","observed_orcids":["https://orcid.org/0000-0001-7053-038X"]},"institutions":[{"id":"https://openalex.org/I80188885","display_name":"Nippon Medical School","ror":"https://ror.org/00krab219","country_code":"JP","type":"education","lineage":["https://openalex.org/I80188885"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ryuji Ohashi","raw_affiliation_strings":["Department of Integrated Diagnostic Pathology, Nippon Medical School"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Integrated Diagnostic Pathology, Nippon Medical School","institution_ids":["https://openalex.org/I80188885"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2383,"has_fulltext":true,"cited_by_count":11,"citation_normalized_percentile":{"value":0.22026948,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":97},"biblio":{"volume":"89","issue":"2","first_page":"128","last_page":"138"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.9160000085830688,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.9160000085830688,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.02459999918937683,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.013500000350177288,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5070000290870667},{"id":"https://openalex.org/keywords/drug-induced-nephrotoxicity","display_name":"drug-induced nephrotoxicity","score":0.8420000076293945},{"id":"https://openalex.org/keywords/renal-complications","display_name":"renal complications","score":0.7110000252723694},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.8560000061988831},{"id":"https://openalex.org/keywords/vegf-inhibitors","display_name":"VEGF inhibitors","score":0.8180000185966492},{"id":"https://openalex.org/keywords/thrombotic-microangiopathy","display_name":"thrombotic microangiopathy","score":0.8619999885559082},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8790000081062317},{"id":"https://openalex.org/keywords/pazopanib","display_name":"pazopanib","score":0.9959999918937683},{"id":"https://openalex.org/keywords/podocytopathy","display_name":"podocytopathy","score":0.9340000152587891},{"id":"https://openalex.org/keywords/minimal-change-disease","display_name":"minimal change disease","score":0.8709999918937683},{"id":"https://openalex.org/keywords/focal-segmental-glomerulosclerosis","display_name":"focal segmental glomerulosclerosis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9950000047683716},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.9750000238418579},{"id":"https://openalex.org/keywords/acute-interstitial-nephritis","display_name":"acute interstitial nephritis","score":0.968999981880188},{"id":"https://openalex.org/keywords/vasculitis","display_name":"vasculitis","score":0.7789999842643738},{"id":"https://openalex.org/keywords/glomerulonephritis","display_name":"glomerulonephritis","score":0.9129999876022339},{"id":"https://openalex.org/keywords/protease-inhibitors","display_name":"protease inhibitors","score":0.6980000138282776},{"id":"https://openalex.org/keywords/mtor-inhibitors","display_name":"mTOR inhibitors","score":0.8820000290870667}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.833899974822998},{"id":"https://openalex.org/C2778415529","wikidata":"https://www.wikidata.org/wiki/Q1435223","display_name":"Focal segmental glomerulosclerosis","level":4,"score":0.6761999726295471},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.4788999855518341},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.4643000066280365},{"id":"https://openalex.org/C2780472472","wikidata":"https://www.wikidata.org/wiki/Q424337","display_name":"Acute kidney injury","level":2,"score":0.4408999979496002},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4392000138759613},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.42410001158714294},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.4138999879360199},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.4059000015258789},{"id":"https://openalex.org/C2778930706","wikidata":"https://www.wikidata.org/wiki/Q504790","display_name":"Nephrotic syndrome","level":2,"score":0.40059998631477356},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.39329999685287476},{"id":"https://openalex.org/C2780368995","wikidata":"https://www.wikidata.org/wiki/Q605006","display_name":"Glomerulonephritis","level":3,"score":0.39010000228881836},{"id":"https://openalex.org/C2781068499","wikidata":"https://www.wikidata.org/wiki/Q3242950","display_name":"Kidney cancer","level":3,"score":0.37790000438690186},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3749000132083893},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36419999599456787},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.3521000146865845},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.34549999237060547},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.3447999954223633},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34369999170303345},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.33869999647140503},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.3264000117778778},{"id":"https://openalex.org/C2777390665","wikidata":"https://www.wikidata.org/wiki/Q5571239","display_name":"Glomerulosclerosis","level":4,"score":0.3240000009536743},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3190999925136566},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2955999970436096},{"id":"https://openalex.org/C2775946357","wikidata":"https://www.wikidata.org/wiki/Q1713037","display_name":"Membranous nephropathy","level":4,"score":0.2793000042438507},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2759999930858612},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.2646999955177307}],"mesh":[{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D057049","descriptor_name":"Thrombotic Microangiopathies","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1272/jnms.jnms.2022_89-221","doi":"https://doi.org/10.1272/jnms.jnms.2022_89-221","is_oa":true,"landing_page_url":"https://doi.org/10.1272/jnms.jnms.2022_89-221","pdf_url":"https://www.jstage.jst.go.jp/article/jnms/advpub/0/advpub_JNMS.2022_89-221/_pdf","source":{"id":"https://openalex.org/S118610483","display_name":"Journal of Nippon Medical School","issn_l":"0048-0444","issn":["0048-0444","1345-4676","1347-3409","1884-0108"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["dongbi-b","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320448","host_organization_name":"Medknow","host_organization_lineage":["https://openalex.org/P4310320448","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Medknow","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Nippon Medical School","raw_type":"journal-article"},{"id":"pmid:34840210","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34840210","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Nippon Medical School = Nippon Ika Daigaku zasshi","raw_type":"Journal Article"},{"id":"pmh:oai:irdb.nii.ac.jp:02879:0005993055","doi":null,"is_oa":true,"landing_page_url":"https://nms.repo.nii.ac.jp/records/2000045","pdf_url":null,"source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Nippon Medical School","raw_type":"journal article"}],"best_oa_location":{"id":"doi:10.1272/jnms.jnms.2022_89-221","doi":"https://doi.org/10.1272/jnms.jnms.2022_89-221","is_oa":true,"landing_page_url":"https://doi.org/10.1272/jnms.jnms.2022_89-221","pdf_url":"https://www.jstage.jst.go.jp/article/jnms/advpub/0/advpub_JNMS.2022_89-221/_pdf","source":{"id":"https://openalex.org/S118610483","display_name":"Journal of Nippon Medical School","issn_l":"0048-0444","issn":["0048-0444","1345-4676","1347-3409","1884-0108"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["dongbi-b","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320448","host_organization_name":"Medknow","host_organization_lineage":["https://openalex.org/P4310320448","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Medknow","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Nippon Medical School","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3217463287.pdf","grobid_xml":"https://content.openalex.org/works/W3217463287.grobid-xml"},"referenced_works_count":72,"referenced_works":["https://openalex.org/W956887705","https://openalex.org/W1524835962","https://openalex.org/W1893566975","https://openalex.org/W1955067112","https://openalex.org/W1974183395","https://openalex.org/W1976431837","https://openalex.org/W1985108443","https://openalex.org/W1989828131","https://openalex.org/W1994993231","https://openalex.org/W2009012098","https://openalex.org/W2023422205","https://openalex.org/W2027887693","https://openalex.org/W2048818094","https://openalex.org/W2054774757","https://openalex.org/W2058743530","https://openalex.org/W2064058305","https://openalex.org/W2064283997","https://openalex.org/W2067380467","https://openalex.org/W2087285553","https://openalex.org/W2103369453","https://openalex.org/W2107046797","https://openalex.org/W2108874630","https://openalex.org/W2115090138","https://openalex.org/W2121314233","https://openalex.org/W2126846432","https://openalex.org/W2137174491","https://openalex.org/W2151327647","https://openalex.org/W2152468013","https://openalex.org/W2161295623","https://openalex.org/W2172076789","https://openalex.org/W2263759961","https://openalex.org/W2269483232","https://openalex.org/W2345522085","https://openalex.org/W2413514895","https://openalex.org/W2416137380","https://openalex.org/W2417136453","https://openalex.org/W2487303921","https://openalex.org/W2550815089","https://openalex.org/W2557098519","https://openalex.org/W2570021565","https://openalex.org/W2572174216","https://openalex.org/W2743419024","https://openalex.org/W2748473012","https://openalex.org/W2778772434","https://openalex.org/W2791299132","https://openalex.org/W2793943975","https://openalex.org/W2794238752","https://openalex.org/W2798115114","https://openalex.org/W2809773917","https://openalex.org/W2883944750","https://openalex.org/W2884372851","https://openalex.org/W2903686952","https://openalex.org/W2904722765","https://openalex.org/W2913574617","https://openalex.org/W2914287567","https://openalex.org/W2914696936","https://openalex.org/W2937282237","https://openalex.org/W2946319627","https://openalex.org/W2947112139","https://openalex.org/W2947311362","https://openalex.org/W2949334838","https://openalex.org/W2950208654","https://openalex.org/W2957912673","https://openalex.org/W2960130441","https://openalex.org/W2962502275","https://openalex.org/W2964371740","https://openalex.org/W2996136049","https://openalex.org/W3010211192","https://openalex.org/W3037575240","https://openalex.org/W3089849844","https://openalex.org/W3092096467","https://openalex.org/W3129109577"],"related_works":["https://openalex.org/W3173219441","https://openalex.org/W2054774757","https://openalex.org/W2148385498","https://openalex.org/W3008160452","https://openalex.org/W4413843597","https://openalex.org/W4411936811","https://openalex.org/W2028118528","https://openalex.org/W2954444361","https://openalex.org/W2466228672","https://openalex.org/W2076723471"],"abstract_inverted_index":{"Among":[0],"recent":[1],"advances":[2],"in":[3,71,167],"cancer":[4],"treatment,":[5],"the":[6,20,77,82,168,216],"emergence":[7],"of":[8,22,32,81,145,204,219],"novel":[9,143],"drugs":[10,35,41],"targeting":[11],"specific":[12],"molecules":[13],"has":[14,207],"considerably":[15],"modulated":[16],"therapeutic":[17],"strategies.":[18],"Despite":[19],"efficacy":[21],"these":[23],"agents,":[24,90],"renal":[25,125,220],"complications":[26,221],"that":[27,53],"are":[28,121,141],"distinct":[29],"from":[30,236],"those":[31],"conventional":[33],"chemotherapeutic":[34],"have":[36,186],"been":[37,188,209],"reported.":[38,189],"Targeted":[39],"therapy":[40],"include":[42,170],"monoclonal":[43,51],"antibodies":[44],"and":[45,60,103,109,117,135,140,174,184,201,227,232],"small-molecule":[46],"agents.":[47],"Bevacizumab":[48],"is":[49,85],"a":[50,142,237],"antibody":[52],"targets":[54],"vascular":[55],"endothelial":[56,68,101],"growth":[57],"factor":[58],"(VEGF)":[59],"blocks":[61],"tumor":[62],"angiogenesis.":[63],"This":[64],"anti-angiogenic":[65],"effect":[66],"causes":[67],"injury,":[69],"resulting":[70],"\"thrombotic":[72],"microangiopathy-like":[73],"lesions\"":[74],"confined":[75],"to":[76,150,160],"glomerulus.":[78],"Segmental":[79],"hyalinosis":[80],"glomerular":[83],"tuft":[84],"also":[86,187,208],"observed.":[87],"Small":[88],"molecular":[89,195,224],"including":[91],"tyrosine":[92],"kinase":[93],"inhibitors":[94,129,200,235],"(TKIs)":[95],"such":[96,131,197],"as":[97,132,161,198],"pazopanib,":[98],"can":[99],"cause":[100,155],"injury":[102],"podocytopathy":[104],"by":[105,178],"blocking":[106],"VEGF":[107],"receptors":[108],"their":[110,151],"downstream":[111],"signaling.":[112],"Minimal":[113],"change":[114],"nephrotic":[115],"syndrome":[116],"focal":[118],"segmental":[119],"glomerulosclerosis":[120],"associated":[122,192,222],"with":[123,193,223],"TKI-induced":[124],"complications.":[126],"Immune":[127],"checkpoint":[128,234],"(ICIs)":[130],"PD-1,":[133],"CTLA-4,":[134],"PD-L1":[136],"modulate":[137],"immune":[138,233],"checkpoints":[139],"form":[144],"immunotherapy":[146],"against":[147],"cancer.":[148],"Owing":[149],"unique":[152],"function,":[153],"ICIs":[154],"inflammatory":[156],"side":[157],"effects":[158],"referred":[159],"immune-related":[162],"adverse":[163],"events":[164],"(irAEs).":[165],"irAEs":[166],"kidney":[169],"acute":[171],"tubulointerstitial":[172],"nephritis":[173],"tubulitis,":[175],"occasionally":[176],"accompanied":[177],"granuloma":[179],"formation.":[180],"Vasculitis,":[181],"thrombotic":[182],"microangiopathy,":[183],"glomerulonephritis":[185],"Renal":[190],"toxicity":[191],"other":[194],"drugs,":[196],"protease":[199],"mammalian":[202],"target":[203],"rapamycin":[205],"inhibitors,":[206],"documented.":[210],"In":[211],"this":[212],"article,":[213],"we":[214],"review":[215],"clinicohistopathological":[217],"aspects":[218],"targeted":[225],"therapies":[226],"focus":[228],"on":[229],"anti-VEGF":[230],"agents":[231],"pathological":[238],"perspective.":[239]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2021-12-06T00:00:00"}